• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣植入术后磁共振弥散加权成像确定的脑栓塞性梗死:预测风险因素的评估及其与后续健康状况的关系。

Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status.

机构信息

Division of Cardiovascular and Neuronal Remodelling, Leeds Institute of Genetics, Health and Therapeutics, University of Leeds, Leeds, UK.

出版信息

Heart. 2012 Jan;98(1):18-23. doi: 10.1136/heartjnl-2011-300065. Epub 2011 Jul 7.

DOI:10.1136/heartjnl-2011-300065
PMID:21737581
Abstract

BACKGROUND

'Silent' cerebral infarction and stroke are complications of transcatheter aortic valve implantation (TAVI).

OBJECTIVE

To assess the occurrence of cerebral infarction, identify predictive risk factors and examine the impact on patient health-related quality of life (HRQoL).

METHODS

Cerebral diffusion weighted MRI of 31 patients with aortic stenosis undergoing CoreValve TAVI was carried out. HRQoL was assessed at baseline and at 30 days by SF-12v2 and EQ5D questionnaires.

RESULTS

New cerebral infarcts occurred in 24/31 patients (77%) and stroke in 2 (6%). Stroke was associated with a greater number and volume of cerebral infarcts. Age (r=0.37, p=0.042), severity of atheroma (arch and descending aorta; r=0.91, p<0.001, r=0.69, p=0.001, respectively) and catheterisation time (r=0.45, p=0.02) were predictors of the number of new cerebral infarcts. HRQoL improved overall: SF-12v2 physical component summary increased significantly (32.4±6.2 vs 36.5±7.2; p=0.03) with no significant change in mental component summary (43.5±11.7 vs. 43.1±14.3; p=0.85). The EQ5D score and Visual Analogue Scale showed no significant change (0.56±0.26 vs. 0.59±0.31; p=0.70, and 54.2±19 vs. 58.2±24; p=0.43).

CONCLUSION

Multiple small cerebral infarcts occurred in 77% of patients with TAVI. The majority of infarcts were 'silent' with clinical stroke being associated with a both higher infarct number and volume. Increased age and the severity of aortic arch atheroma were independent risk factors for the development of new cerebral infarcts. Overall HRQoL improved and there was no association between the number of new cerebral infarcts and altered health status.

摘要

背景

“沉默性”脑梗死和脑卒中是经导管主动脉瓣植入术(TAVI)的并发症。

目的

评估脑梗死的发生情况,确定预测性危险因素,并研究其对患者健康相关生活质量(HRQoL)的影响。

方法

对 31 例主动脉瓣狭窄行 CoreValve TAVI 的患者进行脑弥散加权 MRI。采用 SF-12v2 和 EQ5D 问卷分别在基线和 30 天时评估 HRQoL。

结果

31 例患者中有 24 例(77%)发生新发脑梗死,2 例(6%)发生脑卒中。脑卒中与更多的脑梗死数量和更大的脑梗死体积相关。年龄(r=0.37,p=0.042)、动脉粥样硬化严重程度(主动脉弓和降主动脉;r=0.91,p<0.001,r=0.69,p=0.001)和置管时间(r=0.45,p=0.02)是新脑梗死数量的预测因素。HRQoL 总体上有所改善:SF-12v2 生理成分综合评分显著增加(32.4±6.2 比 36.5±7.2;p=0.03),心理成分综合评分无显著变化(43.5±11.7 比 43.1±14.3;p=0.85)。EQ5D 评分和视觉模拟量表均无显著变化(0.56±0.26 比 0.59±0.31;p=0.70,54.2±19 比 58.2±24;p=0.43)。

结论

TAVI 患者中有 77%发生多发性小面积脑梗死。大多数梗死灶为“沉默性”,临床脑卒中与更高的梗死灶数量和体积相关。年龄增加和主动脉弓粥样硬化严重程度是新发脑梗死的独立危险因素。总体 HRQoL 有所改善,新发脑梗死数量与健康状况改变无关。

相似文献

1
Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status.经导管主动脉瓣植入术后磁共振弥散加权成像确定的脑栓塞性梗死:预测风险因素的评估及其与后续健康状况的关系。
Heart. 2012 Jan;98(1):18-23. doi: 10.1136/heartjnl-2011-300065. Epub 2011 Jul 7.
2
First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions.经导管主动脉瓣介入治疗中新型栓塞转向装置的首例人体应用经验。
EuroIntervention. 2012 May 15;8(1):51-6. doi: 10.4244/EIJV8I1A9.
3
Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging.经股主动脉瓣置换术后脑栓塞的风险和命运:一项前瞻性试点研究与弥散加权磁共振成像。
J Am Coll Cardiol. 2010 Apr 6;55(14):1427-32. doi: 10.1016/j.jacc.2009.12.026. Epub 2010 Feb 24.
4
Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis.老年患者经导管主动脉瓣置换术治疗重度主动脉瓣狭窄 1 年后的生活质量。
EuroIntervention. 2011 Sep;7(5):573-9. doi: 10.4244/EIJV7I5A93.
5
Serial change in health-related quality of life over 1 year after transcatheter aortic valve implantation: predictors of health outcomes.经导管主动脉瓣植入术后 1 年内健康相关生活质量的连续变化:健康结局的预测因素。
J Am Coll Cardiol. 2012 May 8;59(19):1672-80. doi: 10.1016/j.jacc.2012.01.035.
6
Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging.经磁共振成像检测,经心尖主动脉瓣植入术后发生脑栓塞性损伤。
JACC Cardiovasc Interv. 2010 Nov;3(11):1126-32. doi: 10.1016/j.jcin.2010.09.008.
7
Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve.经股动脉与经心尖途径行经皮主动脉瓣植入术治疗中脑栓塞的磁共振成像评估:应用 Edwards Sapiens 瓣膜的对比研究
Eur J Cardiothorac Surg. 2011 Aug;40(2):475-9. doi: 10.1016/j.ejcts.2010.11.070. Epub 2011 Jan 20.
8
Consequence of cerebral embolism after transcatheter aortic valve implantation compared with contemporary surgical aortic valve replacement: effect on health-related quality of life.经导管主动脉瓣植入术后脑栓塞与当代外科主动脉瓣置换术相比的后果:对健康相关生活质量的影响。
Circ Cardiovasc Interv. 2015 Mar;8(3):e001913. doi: 10.1161/CIRCINTERVENTIONS.114.001913.
9
Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches.经导管主动脉瓣植入术后脑栓塞:经股动脉和经心尖途径的比较。
J Am Coll Cardiol. 2011 Jan 4;57(1):18-28. doi: 10.1016/j.jacc.2010.07.036.
10
Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study.经皮经股主动脉瓣植入术后的静默性和显性脑缺血:一项弥散加权磁共振成像研究。
Circulation. 2010 Feb 23;121(7):870-8. doi: 10.1161/CIRCULATIONAHA.109.855866.

引用本文的文献

1
Incidence, Risk Factors, and Stroke Prevention During Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术期间的发病率、危险因素及卒中预防
Rev Cardiovasc Med. 2025 Apr 22;26(4):26867. doi: 10.31083/RCM26867. eCollection 2025 Apr.
2
Cerebral Embolic Protection Devices: Current State of the Art.脑栓塞保护装置:当前技术水平
US Cardiol. 2023 Mar 31;17:e02. doi: 10.15420/usc.2022.12. eCollection 2023.
3
Health-related quality of life after minimal-invasive treatment of aortic valve stenosis in the elderly.老年人主动脉瓣狭窄微创治疗后的健康相关生活质量
J Thorac Dis. 2024 Apr 30;16(4):2274-2284. doi: 10.21037/jtd-23-1509. Epub 2024 Apr 10.
4
Cerebral Protection in Trans-Catheter Aortic Valve Replacement: Review and Contemporary Assessment of Randomized Trial Data.经导管主动脉瓣置换术中的脑保护:随机试验数据的综述与当代评估
Neurohospitalist. 2024 Apr;14(2):157-165. doi: 10.1177/19418744231225680. Epub 2024 Jan 4.
5
Direct transcatheter aortic valve implantation (TAVI) decreases silent cerebral infarction when compared to routine balloon valvuloplasty.与常规球囊瓣膜成形术相比,直接经导管主动脉瓣植入术(TAVI)可减少无症状性脑梗死的发生。
Int J Cardiovasc Imaging. 2023 Oct;39(10):2029-2039. doi: 10.1007/s10554-023-02895-x. Epub 2023 Jun 26.
6
Cerebral ischemic injury after transcatheter aortic valve replacement in patients with pure aortic regurgitation.单纯主动脉瓣反流患者经导管主动脉瓣置换术后的脑缺血性损伤。
J Zhejiang Univ Sci B. 2023 Jun 15;24(6):530-538. doi: 10.1631/jzus.B2200444.
7
Impact of COVID-19 lockdown on match performances in the National Basketball Association.新冠疫情封锁对美国职业篮球联赛比赛表现的影响。
Front Psychol. 2022 Nov 22;13:951779. doi: 10.3389/fpsyg.2022.951779. eCollection 2022.
8
Silent Brain Infarction, Delirium, and Cognition in Three Invasive Cardiovascular Procedures: a Systematic Review.三种侵入性心血管手术中的无症状脑梗死、谵妄与认知:一项系统评价
Neuropsychol Rev. 2023 Jun;33(2):474-491. doi: 10.1007/s11065-022-09548-1. Epub 2022 Jul 8.
9
Transcatether Aortic Valve Implantation to Treat Degenerated Surgical Bioprosthesis: Focus on the Specific Procedural Challenges.经导管主动脉瓣植入术治疗退化的外科生物瓣膜:关注特定的手术挑战。
Front Cardiovasc Med. 2022 May 31;9:895477. doi: 10.3389/fcvm.2022.895477. eCollection 2022.
10
Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: the PROTEMBO C Trial.新型经导管主动脉瓣植入术脑保护装置的安全性和性能:PROTEMBO C 试验。
EuroIntervention. 2022 Sep 20;18(7):590-597. doi: 10.4244/EIJ-D-22-00238.